Neurosteroid-mediated regulation of brain innate immunity in HIV/AIDS: DHEA-S suppresses neurovirulence

FASEB Journal

Volumn 27, Issue 2, 2013, Pages 725-737

  Maingat, Ferdinand G ^a   Polyak, Maria J ^a   Paul, Amber M ^a   Vivithanaporn, Pornpun ^a,b   Noorbakhsh, Farshid ^a   Ahboucha, Samir ^c   Baker, Glen B ^a   Pearson, Keir ^a   Power, Christopher ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Mahidol University   (Thailand)

^c CADI AYYAD UNIVERSITY   (Morocco)

Author keywords

FIV; Glia; Inflammation; Neuron

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; BETA CYCLODEXTRIN; CD3 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PRASTERONE SULFATE; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN; CD4 LYMPHOCYTE COUNT; CELL VIABILITY; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; FETUS; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOREACTIVITY; IN VIVO STUDY; INNATE IMMUNITY; MACROPHAGE; NERVE CELL LESION; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; STEROIDOGENESIS; VIRUS REPLICATION; VIRUS VIRULENCE;

AIDS DEMENTIA COMPLEX; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CATS; DEHYDROEPIANDROSTERONE SULFATE; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; HIV-1; HUMANS; IMMUNITY, INNATE; IMMUNODEFICIENCY VIRUS, FELINE; PREGNANCY; VIRULENCE; VIRUS REPLICATION;

EID: 84873433986     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-215079     Document Type: Article

References (82)

1. Truss, M., and Beato, M. (1993) Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr. Rev. 14, 459-479
2. Evans, R. M. (1988) The steroid and thyroid hormone receptor superfamily. Science 240, 889-895
3. Paul, S. M., and Purdy, R. H. (1992) Neuroactive steroids. FASEB J. 6, 2311-2322
4. Rupprecht, R. (2003) Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 28, 139-168
5. Rupprecht, R., and Holsboer, F. (1999) Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci. 22, 410-416
6. Epstein, L. G., and Gelbard, H. A. (1999) HIV-1-induced neuronal injury in the developing brain. J. Leukoc. Biol. 65, 453-457
7. Baulieu, E. E., Robel, P., and Schumacher, M. (2001) Neurosteroids: beginning of the story. Int. Rev. Neurobiol. 46, 1-32
8. Warner, M., and Gustafsson, J. A. (1995) Cytochrome P450 in the brain: neuroendocrine functions. Front. Neuroendocrinol. 16, 224-236
9. Lambert, J. J., Belelli, D., Hill-Venning, C., and Peters, J. A. (1995) Neurosteroids and GABAA receptor function. Trends Pharmacol. Sci. 16, 295-303
10. Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., and Paul, S. M. (1986) Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232, 1004-1007
11. Park-Chung, M., Wu, F. S., and Farb, D. H. (1994) 3 alphahydroxy-5 beta-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons. Mol. Pharmacol. 46, 146-150
12. Weaver, C. E., Jr., Marek, P., Park-Chung, M., Tam, S. W., and Farb, D. H. (1997) Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-d-aspartate receptor. Proc. Natl. Acad. Sci. U. S. A. 94, 10450-10454
13. Weaver, C. E., Jr., Park-Chung, M., Gibbs, T. T., and Farb, D. H. (1997) 17beta-Estradiol protects against NMDA-induced excito-toxicity by direct inhibition of NMDA receptors. Brain Res. 761, 338-341
14. Wu, F. S., Gibbs, T. T., and Farb, D. H. (1991) Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-d-aspartate receptor. Mol. Pharmacol. 40, 333-336
15. Dong, L., Zhu, Y., Dong, Y., Yang, J., Zhao, Y., Qi, Y., Wu, P., and Zheng, P. (2009) Neuroactive steroid dehydroepiandrosterone sulfate inhibits 5-hydroxytryptamine (5-HT)-evoked glutamate release via activation of sigma-1 receptors and then inhibition of 5-HT3 receptors in rat prelimbic cortex. J. Pharmacol. Exp. Ther. 330, 494-501
16. Wetzel, C. H., Hermann, B., Behl, C., Pestel, E., Rammes, G., Zieglgansberger, W., Holsboer, F., and Rupprecht, R. (1998) Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. Mol. Endocrinol. 12, 1441-1451
17. Maurice, T., Urani, A., Phan, V. L., and Romieu, P. (2001) The interaction between neuroactive steroids and the sigma1 receptor function: behavioral consequences and therapeutic opportunities. Brain Res. Brain Res. Rev. 37, 116-132
18. Dubrovsky, B. (2006) Neurosteroids, neuroactive steroids, and symptoms of affective disorders. Pharmacol. Biochem. Behav. 84, 644-655
19. Dubrovsky, B. O. (2005) Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 169-192
20. Eser, D., Schule, C., Baghai, T. C., Romeo, E., Uzunov, D. P., and Rupprecht, R. (2006) Neuroactive steroids and affective disorders. Pharmacol. Biochem. Behav. 84, 656-666
21. MacKenzie, E. M., Odontiadis, J., Le Melledo, J. M., Prior, T. I., and Baker, G. B. (2007) The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders. Cell. Mol. Neurobiol. 27, 541-574
22. Strous, R. D., Maayan, R., and Weizman, A. (2006) The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside. Eur. Neuropsychopharmacol. 16, 155-169
23. Le Melledo, J. M., and Baker, G. B. (2002) Neuroactive steroids and anxiety disorders. J. Psychiatry Neurosci. 27, 161-165
24. Ahboucha, S., and Butterworth, R. F. (2007) The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy. Metab. Brain Dis. 22, 291-308
25. Marx, C. E., Bradford, D. W., Hamer, R. M., Naylor, J. C., Allen, T. B., Lieberman, J. A., Strauss, J. L., and Kilts, J. D. (2011) Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence. Neuroscience 191, 78-90
26. Luchetti, S., Huitinga, I., and Swaab, D. F. (2011) Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis. Neuroscience 191, 6-21
27. Schule, C., Eser, D., Baghai, T. C., Nothdurfter, C., Kessler, J. S., and Rupprecht, R. (2011) Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugsNeuroscience 191, 55-77
28. Van Marle, G., and Power, C. (2005) Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinantJ. Neurovirol. 11, 107-128
29. Rackstraw, S. (2011) HIV-related neurocognitive impairment. A review. Psychol. Health Med. 16, 548-563
30. Wright, E. (2011) Neurocognitive impairment and neuroCART. Curr. Opin. HIV AIDS 6, 303-308
31. Bendinelli, M., Pistello, M., Lombardi, S., Poli, A., Garzelli, C., Matteucci, D., Ceccherini-Nelli, L., Malvaldi, G., and Tozzini, F. (1995) Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin. Microbiol. Rev. 8, 87-112
32. Maingat, F., Vivithanaporn, P., Zhu, Y., Taylor, A., Baker, G., Pearson, K., and Power, C. (2009) Neurobehavioral performance in feline immunodeficiency virus infection: integrated analysis of viral burden, neuroinflammation, and neuronal injury in cortex. J. Neurosci. 29, 8429-8437
33. Zink, M. C., Laast, V. A., Helke, K. L., Brice, A. K., Barber, S. A., Clements, J. E., and Mankowski, J. L. (2006) From mice to macaques-animal models of HIV nervous system disease. Curr. HIV Res. 4, 293-305
34. Power, C., Moench, T., Peeling, J., Kong, P. A., and Langelier, T. (1997) Feline immunodeficiency virus causes increased glutamate levels and neuronal loss in brain. Neuroscience 77, 1175-1185
35. Poli, A., Pistello, M., Carli, M. A., Abramo, F., Mancuso, G., Nicoletti, E., and Bendinelli, M. (1999) Tumor necrosis factoralpha and virus expression in the central nervous system of cats infected with feline immunodeficiency virus. J. Neurovirol. 5, 465-473
36. Noorbakhsh, F., Tang, Q., Liu, S., Silva, C., van Marle, G., and Power, C. (2006) Lentivirus envelope protein exerts differential neuropathogenic effects depending on the site of expression and target cell. Virology 348, 260-276
37. Ritsner, M. S., and Strous, R. D. (2010) Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: a multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA. J. Psychiatr. Res. 44, 75-80
38. Ritsner, M. S. (2011) The clinical and therapeutic potentials of dehydroepiandrosterone and pregnenolone in schizophrenia. Neuroscience 191, 91-100
39. Charalampopoulos, I., Remboutsika, E., Margioris, A. N., and Gravanis, A. (2008) Neurosteroids as modulators of neurogenesis and neuronal survival. Trends Endocrinol. Metab. 19, 300-307
40. Schumacher, M., Robel, P., and Baulieu, E. E. (1996) Development and regeneration of the nervous system: a role for neurosteroids. Dev. Neurosci. 18, 6-21
41. Zhu, Y., Vergote, D., Pardo, C., Noorbakhsh, F., McArthur, J. C., Hollenberg, M. D., Overall, C. M., and Power, C. (2009) CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy. FASEB J. 23, 2928-2941
42. Power, C., Buist, R., Johnston, J. B., Del Bigio, M. R., Ni, W., Dawood, M. R., and Peeling, J. (1998) Neurovirulence in feline immunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression. J. Virol. 72, 9109-9115
43. Bhat, R. K., Ellestad, K. K., Wheatley, B. M., Warren, R., Holt, R. A., and Power, C. (2011) Age-and disease-dependent HERV-W envelope allelic variation in brain: association with neuroimmune gene expression. PLoS One 6, e19176
44. Noorbakhsh, F., Vergnolle, N., McArthur, J. C., Silva, C., Vodjgani, M., Andrade-Gordon, P., Hollenberg, M. D., and Power, C. (2005) Proteinase-activated receptor-2 indiction by neuroinflammation prevents neuronal death during HIV infection. J. Immunol. 174, 7320-7329
45. Ahboucha, S., Butterworth, R. F., Pomier-Layrargues, G., Vincent, C., Hassoun, Z., and Baker, G. B. (2008) Neuroactive steroids and fatigue severity in patients with primary biliary cirrhosis and hepatitis C. Neurogastroenterol. Motil. 20, 671-679
46. Afkhami-Goli, A., Noorbakhsh, F., Keller, A. J., Vergnolle, N., Westaway, D., Jhamandas, J. H., Andrade-Gordon, P., Hollenberg, M. D., Arab, H., Dyck, R. H., and Power, C. (2007) Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer's disease. J. Immunol. 179, 5493-5503
47. Power, C., McArthur, J. C., Nath, A., Wehrly, K., Mayne, M., Nishio, J., Langelier, T., Johnson, R. T., and Chesebro, B. (1998) Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J. Virol. 72, 9045-9053
48. Maingat, F., Halloran, B., Acharjee, S., van Marle, G., Church, D., Gill, M. J., Uwiera, R. R., Cohen, E. A., Meddings, J., Madsen, K., and Power, C. (2011) Inflammation and epithelial cell injury in AIDS enteropathy: involvement of endoplasmic reticulum stress. FASEB J. 25, 2211-2220
49. Black, S. M., Szklarz, G. D., Harikrishna, J. A., Lin, D., Wolf, C. R., and Miller, W. L. (1993) Regulation of proteins in the cholesterol side-chain cleavage system in JEG-3 and Y-1 cells. Endocrinology 132, 539-545
50. Zhu, Y., Jones, G., Tsutsui, S., Opii, W., Liu, S., Silva, C., Butterfield, D. A., and Power, C. (2005) Lentivirus infection causes neuroinflammation and neuronal injury in dorsal root ganglia: pathogenic effects of STAT-1 and inducible nitric oxide synthase. J. Immunol. 175, 1118-1126
51. Boven, L. A., Noorbakhsh, F., Bouma, G., van der Zee, R., Vargas, D. L., Pardo, C., McArthur, J. C., Nottet, H. S., and Power, C. (2007) Brain-derived human immunodeficiency vi-rus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation. J. Neurovirol. 13, 173-184
52. Power, C., Henry, S., Del Bigio, M. R., Larsen, P. H., Corbett, D., Imai, Y., Yong, V. W., and Peeling, J. (2003) Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann. Neurol. 53, 731-742
53. Johnston, J., and Power, C. (1999) Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: implications for vector development. J. Virol. 73, 2491-2498
54. Johnston, J. B., Silva, C., Hiebert, T., Buist, R., Dawood, M. R., Peeling, J., and Power, C. (2002) Neurovirulence depends on virus input titer in brain in feline immunodeficiency virus infection: evidence for activation of innate immunity and neuronal injury. J. Neurovirol. 8, 420-431
55. Maninger, N., Wolkowitz, O. M., Reus, V. I., Epel, E. S., and Mellon, S. H. (2009) Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front. Neuroendocrinol. 30, 65-91
56. Levine, M. S., Lloyd, R. L., Fisher, R. S., Hull, C. D., and Buchwald, N. A. (1987) Sensory, motor and cognitive alterations in aged cats. Neurobiol. Aging 8, 253-263
57. McVea, D. A., and Pearson, K. G. (2006) Long-lasting memories of obstacles guide leg movements in the walking cat. J. Neurosci. 26, 1175-1178
58. Kennedy, J. M., Hoke, A., Zhu, Y., Johnston, J. B., van Marle, G., Silva, C., Zochodne, D. W., and Power, C. (2004) Peripheral neuropathy in lentivirus infection: evidence of inflammation and axonal injury. AIDS 18, 1241-1250
59. Tsutsui, S., Vergote, D., Shariat, N., Warren, K., Ferguson, S. S., and Power, C. (2008) Glucocorticoids regulate innate immunity in a model of multiple sclerosis: reciprocal interactions between the A1 adenosine receptor and beta-arrestin-1 in monocytoid cells. FASEB J. 22, 786-796
60. Mellon, S. H. (2007) Neurosteroid regulation of central nervous system development. Pharmacol. Ther. 116, 107-124
61. Griffin, L. D., Gong, W., Verot, L., and Mellon, S. H. (2004) Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nat. Med. 10, 704-711
62. Hoffman, S. W., Virmani, S., Simkins, R. M., and Stein, D. G. (2003) The delayed administration of dehydroepiandrosterone sulfate improves recovery of function after traumatic brain injury in rats. J. Neurotrauma 20, 859-870
63. Milman, A., Zohar, O., Maayan, R., Weizman, R., and Pick, C. G. (2008) DHEAS repeated treatment improves cognitive and behavioral deficits after mild traumatic brain injury. Eur. Neuropsychopharmacol. 18, 181-187
64. McArthur, J. C., Brew, B. J., and Nath, A. (2005) Neurological complications of HIV infection. Lancet Neurol. 4, 543-555
65. Power, C., Boisse, L., Rourke, S., and Gill, M. J. (2009) NeuroAIDS: an evolving epidemic. Can. J. Neurol. Sci. 36, 285-295
66. Traish, A. M., Kang, H. P., Saad, F., and Guay, A. T. (2011) Dehydroepiandrosterone (DHEA)- A precursor steroid or an active hormone in human physiology (CME). J. Sex Med. 8, 2960-2982
67. Mellon, S. H., and Griffin, L. D. (2002) Neurosteroids: biochemistry and clinical significance. Trends Endocrinol. Metab. 13, 35-43
68. Mellon, S. H., and Griffin, L. D. (2002) Synthesis, regulation, and function of neurosteroids. Endocr. Res. 28, 463
69. Noorbakhsh, F., Ellestad, K. K., Maingat, F., Warren, K. G., Han, M. H., Steinman, L., Baker, G. B., and Power, C. (2011) Impaired neurosteroid synthesis in multiple sclerosis. Brain 134, 2703-2721
70. Losel, R. M., Falkenstein, E., Feuring, M., Schultz, A., Tillmann, H. C., Rossol-Haseroth, K., and Wehling, M. (2003) Nongenomic steroid action: controversies, questions, and answers. Physiol. Rev. 83, 965-1016
71. Kalimi, M., Shafagoj, Y., Loria, R., Padgett, D., and Regelson, W. (1994) Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA). Mol. Cell. Biochem. 131, 99-104
72. Barger, S. W., Chavis, J. A., and Drew, P. D. (2000) Dehydroepiandrosterone inhibits microglial nitric oxide production in a stimulus-specific manner. J. Neurosci. Res. 62, 503-509
73. Bologa, L., Sharma, J., and Roberts, E. (1987) Dehydroepiandrosterone and its sulfated derivative reduce neuronal death and enhance astrocytic differentiation in brain cell cultures. J. Neurosci. Res. 17, 225-234
74. Abrams, D. I., Shade, S. B., Couey, P., McCune, J. M., Lo, J., Bacchetti, P., Chang, B., Epling, L., Liegler, T., and Grant, R. M. (2007) Dehydroepiandrosterone (DHEA) effects on HIV replication and host immunity: a randomized placebo-controlled study. AIDS Res. Hum. Retroviruses 23, 77-85
75. Piketty, C., Jayle, D., Leplege, A., Castiel, P., Ecosse, E., Gonzalez-Canali, G., Sabatier, B., Boulle, N., Debuire, B., Le Bouc, Y., Baulieu, E. E., and Kazatchkine, M. D. (2001) Double-blind placebo-controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease. Clin. Endocrinol. (Oxf.) 55, 325-330
76. Gao, X., and Chen, J. (2011) Mild traumatic brain injury results in extensive neuronal degeneration in the cerebral cortex. J. Neuropathol. Exp. Neurol. 70, 183-191
77. Nigam, R., El-Nour, H., Amatya, B., and Nordlind, K. (2010) GABA and GABA(A) receptor expression on immune cells in psoriasis: a pathophysiological role. Arch. Dermatol. Res. 302, 507-515
78. Lombardi, G., Dianzani, C., Miglio, G., Canonico, P. L., and Fantozzi, R. (2001) Characterization of ionotropic glutamate receptors in human lymphocytes. Br. J. Pharmacol. 133, 936-944
79. Borjabad, A., Morgello, S., Chao, W., Kim, S. Y., Brooks, A. I., Murray, J., Potash, M. J., and Volsky, D. J. (2011) Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders. PLoS Pathog. 7, e1002213
80. Pedersen, N. C., North, T. W., Rigg, R., Reading, C., Higgins, J., Leutenegger, C., and Henderson, G. L. (2003) 16alpha-bromoepiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: initial enhancement leading to longterm suppression. Vet. Immunol. Immunopathol. 94, 133-148
81. Scott-Sheldon, L. A., Kalichman, S. C., Carey, M. P., and Fielder, R. L. (2008) Stress management interventions for HIV-adults: a meta-analysis of randomized controlled trials, 1989 to 2006. Health Psychol. 27, 129-139
82. Roy, A., and Hooper, D. C. (2007) Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. J. Virol. 81, 7993-7998